These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. At the stem of youth and health. Beltrami AP; Cesselli D; Beltrami CA Pharmacol Ther; 2011 Jan; 129(1):3-20. PubMed ID: 20965211 [TBL] [Abstract][Full Text] [Related]
3. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Minamino T; Komuro I Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):637-48. PubMed ID: 18762784 [TBL] [Abstract][Full Text] [Related]
4. Regenerative medicine: a primer for paediatricians. Polak DJ Early Hum Dev; 2009 Nov; 85(11):685-9. PubMed ID: 19783108 [TBL] [Abstract][Full Text] [Related]
5. Regenerative medicine based on muscle stem cells. Huard J J Musculoskelet Neuronal Interact; 2008; 8(4):337. PubMed ID: 19147965 [No Abstract] [Full Text] [Related]
6. Auto repair on the aging stem cell superhighway. Edelberg JM Sci Aging Knowledge Environ; 2002 Sep; 2002(35):pe13. PubMed ID: 14603002 [TBL] [Abstract][Full Text] [Related]
7. Chemical control of stem cell fate and developmental potential. Lyssiotis CA; Lairson LL; Boitano AE; Wurdak H; Zhu S; Schultz PG Angew Chem Int Ed Engl; 2011 Jan; 50(1):200-42. PubMed ID: 21184400 [TBL] [Abstract][Full Text] [Related]
8. Nanoscaffold based stem cell regeneration therapy: recent advancement and future potential. Prakash S; Khan A; Paul A Expert Opin Biol Ther; 2010 Dec; 10(12):1649-61. PubMed ID: 20954792 [TBL] [Abstract][Full Text] [Related]
9. Contemplating the bright future of stem cell therapy for cardiovascular disease. Sánchez PL; San Román JA; Villa A; Fernández ME; Fernández-Avilés F Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S138-51. PubMed ID: 16501622 [TBL] [Abstract][Full Text] [Related]
10. [Gene therapy and regenerative medicine for metabolic syndrome]. Sonoyama T; Sone M; Nakao K Nihon Rinsho; 2011 Jan; 69 Suppl 1():716-20. PubMed ID: 21766687 [No Abstract] [Full Text] [Related]
11. Mechanisms and significance of progenitor cell reduction in the metabolic syndrome. Fadini GP; Agostini C; Boscaro E; Avogaro A Metab Syndr Relat Disord; 2009 Feb; 7(1):5-10. PubMed ID: 19183074 [TBL] [Abstract][Full Text] [Related]
12. Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation. Madonna R; Engel FB; Davidson SM; Ferdinandy P; Gorbe A; Sluijter JP; Van Laake LW Curr Drug Targets; 2015; 16(8):780-5. PubMed ID: 25479545 [TBL] [Abstract][Full Text] [Related]
13. Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells. Tongers J; Losordo DW J Am Soc Nephrol; 2007 Nov; 18(11):2843-52. PubMed ID: 17942950 [TBL] [Abstract][Full Text] [Related]
14. Endothelial progenitor cells in regenerative medicine and cancer: a decade of research. Roncalli JG; Tongers J; Renault MA; Losordo DW Trends Biotechnol; 2008 May; 26(5):276-83. PubMed ID: 18359114 [TBL] [Abstract][Full Text] [Related]
18. Making stem cells count for global health. McMahon DS; Thorsteinsdóttir H Regen Med; 2011 Nov; 6(6 Suppl):163-6. PubMed ID: 21999282 [TBL] [Abstract][Full Text] [Related]
19. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Erusalimsky JD; Kurz DJ Exp Gerontol; 2005; 40(8-9):634-42. PubMed ID: 15970413 [TBL] [Abstract][Full Text] [Related]
20. Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? Ebert AD; Diecke S; Chen IY; Wu JC EMBO Mol Med; 2015 Sep; 7(9):1090-103. PubMed ID: 26183451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]